We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
agreed wasted opportunity I'm afraid. but maybe just maybe?
The.Italian.
We may have a product, but unfortunately the men at the top have wasted the early opportunity. Just think where we would be if both the EU and US had used the 20 dose can in the first place. I am not suggesting sales would have been any different in the EU, but we would be where we are now 2 years ago and then launching with a variation and 12 dose canister. Unfortunately the company was driven by too much greed (money fountain and all that), like all of us... :-). The only difference is; none of us keeps getting paid for our mistakes....... LOL
so much luck in it bignose. didi tell you i was in synairgen and sold out the day before (yes) it went up 550% in a day.iconsole myself that i only had a very small holding and probably wouldn't have held for the full gain anyway.200%would have been nice though.no doubt we all have these stories.agree with your thoughts here especially hk market hadn't thought of that.what has been disappointing in a sense here is that we have invested in something that actually produces a product and can be sold.not like a miner when you are hoping to find some thing or a covid spec which might fly or crashh on results etc.in other words it seemed (at least after approval)a "proper" investment. sorry thats rambling but i expect you know what i mean. anyway i am feeling a tad more positive that a couple of months ago.
The.Italian
It had a market cap fluctuating between 4 and 6 mill GBP, so it has done quite well in the short term. Going by the RNS it looks like it could go up a few times more come Sept and if the results of the internal third stage pre in vivo study are positive. Unfortunately I didn't have any free cash to throw at it as I was waiting for funds to come liquid and available, which have been delayed. Mind you, there is still time to invest since you know as well as me how fickle the markets are and how quickly an SP can rise and fall on sentiments alone with no real logic behind price movements. especially for low cap companies currently like this one. This will surely fly on the shirt tails of C-19 with a possible mkt cap of 200mill (this is based on nothing more than achievements I have witnessed by other companies mentioning links to C-19).
A bit like here. We are bouncing around near the bottom, which, looking at price movements compared to volumes (1m buy and no movement yet 10k buy or sell can move the SP 3 to 5%)...is again showing no logic whatsoever. I'm sure once news of the Phase II completion is announced, we could see this back near the 0.3 mark and if a US licensee commits, the doors could fly open with no prisoners taken. Just my opinion based on how significant the drop has been with no positive news at hand. Hopefully the change in HK market status wont effect it too much. It could even be positive if it opens the doors to mainland investors, which have been kept under lock and key. (Very difficult for a mainland pi investor to buy on the HK stock market without some jiggery-pokery to open an investment account etc in HK.
So we wait and see if incompetence once again raises its ugly head to knock us back down again....lol.
apologies for the off topic post, but i see N4P has had a very good day today bignose. not sure how it compares to when you mentioned it, as have kept an eye on but didn't buy in. if you did give it a go i hope it has worked out for you.